Aurelius Cusumano Md - Massapequa, New York 11758

Aurelius Cusumano Md is categorized under Doctors in Massapequa, NY .

Business Name: Aurelius Cusumano Md
Address: 747 North Broadway # 1, Massapequa, New York 11758
Phone Number: (516) 798-4756
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:
Related Businesses: Eisen Seth D MD - Massapequa, NY 11758
Illman Arnold M MD - Massapequa, NY 11758
Stapen Richard L MD - Massapequa, NY 11758
Antoniadis Athanasi MD - Massapequa, NY 11758
Gasparini Mauro MD - Massapequa, NY 11758
Rooney John E MD - Massapequa, NY 11758
Fogel Robert MD - Massapequa, NY 11758
Fox Stanley A MD - Massapequa, NY 11758
Sisselman Jill MD - Massapequa, NY 11758
Mucciolo Robert MD - Massapequa, NY 11758
Adiyody Joseph V MD - Massapequa, NY 11758
Ticker Jonathan B MD - Massapequa, NY 11758
Alleva Michael MD - Massapequa, NY 11758
Khodadadian Jonathan J MD - Massapequa, NY 11758
Nepomuceno Kathleen C MD - Massapequa, NY 11758
Ricca Paul DO - Massapequa, NY 11758
Joseph Thomas DO - Massapequa, NY 11758
Island Family Medicine - Massapequa, NY 11758
Rai Rohit K MD - Massapequa, NY 11758
Luo Wayne MD - Massapequa, NY 11758

The company Aurelius Cusumano Md provides B2C services in the form of Doctors from its single location in New York. 1 to 4 employees work for Aurelius Cusumano Md, and the business now earns $100.000 to $499.999 per annum.

Aurelius Cusumano Md was launched in 2010 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 . To contact Aurelius Cusumano Md, please call with the phone number (516) 798-4756 or visit its single location at 747 North Broadway # 1 in Massapequa, New York 11758.

The location of the single location can also be found using the coordinates . Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.